Brian A. Leuthner
2016 - Edge Therapeutics
In 2016, Brian A. Leuthner earned a total compensation of $1.8M as President and Chief Executive Officer at Edge Therapeutics, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $266,475 |
|---|---|
| Option Awards | $1,106,719 |
| Salary | $467,500 |
| Total | $1,840,694 |
Leuthner received $1.1M in option awards, accounting for 60% of the total pay in 2016.
Leuthner also received $266.5K in non-equity incentive plan and $467.5K in salary.
Rankings
In 2016, Brian A. Leuthner's compensation ranked 5,273rd out of 14,075 executives tracked by ExecPay. In other words, Leuthner earned more than 62.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,273 out of 14,075 | 63rd |
Division Manufacturing | 1,895 out of 5,486 | 66th |
Major group Chemicals And Allied Products | 602 out of 1,900 | 68th |
Industry group Drugs | 449 out of 1,543 | 71st |
Industry Pharmaceutical Preparations | 357 out of 1,173 | 70th |
Source: SEC filing on April 25, 2018.
Leuthner's colleagues
We found two more compensation records of executives who worked with Brian A. Leuthner at Edge Therapeutics in 2016.